Gf Fund Management Co. Ltd. Eton Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 527 shares of ETON stock, worth $8,906. This represents 0.0% of its overall portfolio holdings.
Number of Shares
527Holding current value
$8,906% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETON
# of Institutions
108Shares Held
15.9MCall Options Held
103KPut Options Held
0-
Opaleye Management Inc. Boston, MA2.86MShares$48.3 Million10.4% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.03MShares$34.3 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$22.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT1.18MShares$19.9 Million1.04% of portfolio
-
Morgan Stanley New York, NY586KShares$9.9 Million0.0% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $428M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...